Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany. The Company is also focused on regulatory approval and commercialization of medical products for European markets. Its diagnostic products include COVID-19 PCR Diagnostic Kit, Peri-Implantitis Oral Biosensor, and H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors. Its subsidiaries include XPhyto Laboratories Inc., Bunker Pflanzenextrakte GmbH, Vektor Pharma TF GmbH, BioNxt Europe GmbH, and 3a-diagnostics GmbH, among others.


CSE:BNXT - Post by User

Comment by Adwarion May 03, 2021 9:02am
124 Views
Post# 33112961

RE:New article

RE:New article
 English Translation: "In the fight against corona, fast PCR tests are the more effective solution " In Germany, what is going on is currently being tested. Unfortunately, the rapid tests are unreliable. The Canadian-German company XPhyto is now starting up with a PCR test. Capital spoke to COO Wolfgang Probst about the advantages of this test variant by Monika Dunkel May 1, 2021 The rapid tests available up to now are considered unreliable The whole of Germany is crazy about rapid tests, millions of tests are carried out every day in companies, schools, daycare centers. But science is unanimous. Rapid tests, previously offered as antigen tests, will not get us out of the pandemic. Because they overlook too many infectious people, around 40 percent on average. PCR tests, the gold standard among tests, are more reliable. Until now, only these had to be evaluated in a laborious manner in the laboratory; the result usually came a day later. Now more and more manufacturers are entering the market who offer fast mobile PCR tests. The Canadian-German company XPhyto has had EU approval for the ultra-fast PCR test Covid-ID Lab since the beginning of April. COO Wolfgang Probst on the opportunities and hurdles of the procedure."
<< Previous
Bullboard Posts
Next >>